VolitionRx Statistics

Total Valuation

VolitionRx has a market cap or net worth of $51.20 million. The enterprise value is $51.67 million.

Market Cap	51.20M
Enterprise Value	51.67M

Important Dates

The next estimated earnings date is Monday, March 24, 2025, after market close.

Earnings Date	Mar 24, 2025
Ex-Dividend Date	n/a

Share Statistics

VolitionRx has 92.66 million shares outstanding. The number of shares has increased by 26.18% in one year.

Current Share Class	92.66M
Shares Outstanding	92.66M
Shares Change (YoY)	+26.18%
Shares Change (QoQ)	+6.31%
Owned by Insiders (%)	7.77%
Owned by Institutions (%)	9.63%
Float	63.07M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	35.66
Forward PS	7.54
PB Ratio	-2.26
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	40.18
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.22

Current Ratio	0.22
Quick Ratio	0.19
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-98.03

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-122.00%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	170.37%
Revenue Per Employee	$11,689
Profits Per Employee	-$271,570
Employee Count	110
Asset Turnover	0.08
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -47.38% in the last 52 weeks. The beta is 1.21, so VolitionRx's price volatility has been higher than the market average.

Beta (5Y)	1.21
52-Week Price Change	-47.38%
50-Day Moving Average	0.61
200-Day Moving Average	0.66
Relative Strength Index (RSI)	41.15
Average Volume (20 Days)	103,077

Short Selling Information

The latest short interest is 544,795, so 0.59% of the outstanding shares have been sold short.

Short Interest	544,795
Short Previous Month	570,479
Short % of Shares Out	0.59%
Short % of Float	0.86%
Short Ratio (days to cover)	5.18

Income Statement

In the last 12 months, VolitionRx had revenue of $1.29 million and -$29.87 million in losses. Loss per share was -$0.36.

Revenue	1.29M
Gross Profit	1.29M
Operating Income	-29.98M
Pretax Income	-34.91M
Net Income	-29.87M
EBITDA	-28.87M
EBIT	-29.98M
Loss Per Share	-$0.36

Full Income Statement

Balance Sheet

The company has $5.41 million in cash and $5.89 million in debt, giving a net cash position of -$472,095 or -$0.01 per share.

Cash & Cash Equivalents	5.41M
Total Debt	5.89M
Net Cash	-472,095
Net Cash Per Share	-$0.01
Equity (Book Value)	-22.64M
Book Value Per Share	-0.23
Working Capital	-23.48M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$14.01 million and capital expenditures -$513,620, giving a free cash flow of -$14.53 million.

Operating Cash Flow	-14.01M
Capital Expenditures	-513,620
Free Cash Flow	-14.53M
FCF Per Share	-$0.16

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-2,331.90%
Pretax Margin	-2,348.72%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

VolitionRx does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-26.18%
Shareholder Yield	-26.18%
Earnings Yield	-58.35%
FCF Yield	-28.38%

Analyst Forecast

The average price target for VolitionRx is $4.17, which is 654.75% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$4.17
Price Target Difference	654.75%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	176.85%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

VolitionRx has an Altman Z-Score of -33.56 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-33.56
Piotroski F-Score	2